147 related articles for article (PubMed ID: 32986099)
1. The Exclusion of Older Persons From Vaccine and Treatment Trials for Coronavirus Disease 2019-Missing the Target.
Helfand BKI; Webb M; Gartaganis SL; Fuller L; Kwon CS; Inouye SK
JAMA Intern Med; 2020 Nov; 180(11):1546-1549. PubMed ID: 32986099
[TBL] [Abstract][Full Text] [Related]
2. Coronavirus disease 2019 and clinical research in U.S. nursing homes.
Quinn CC; Adams AS; Magaziner JS; Gurwitz JH
J Am Geriatr Soc; 2021 Jul; 69(7):1748-1751. PubMed ID: 33872385
[No Abstract] [Full Text] [Related]
3. COVID-19 Vaccine Considerations during Pregnancy and Lactation.
Blumberg D; Sridhar A; Lakshminrusimha S; Higgins RD; Saade G
Am J Perinatol; 2021 May; 38(6):523-528. PubMed ID: 33932943
[No Abstract] [Full Text] [Related]
4. What Are COVID-19 Vaccines?
Hartert TV; Sockrider M
Am J Respir Crit Care Med; 2021 May; 203(9):P22-P23. PubMed ID: 33759735
[No Abstract] [Full Text] [Related]
5. COVID-19 vaccination in our transplant recipients: The time is now.
Aslam S; Goldstein DR; Vos R; Gelman AE; Kittleson MM; Wolfe C; Danziger-Isakov L
J Heart Lung Transplant; 2021 Mar; 40(3):169-171. PubMed ID: 33487534
[TBL] [Abstract][Full Text] [Related]
6. Prioritizing second-generation SARS-CoV-2 vaccines through low-dosage challenge studies.
Steuwer B; Jamrozik E; Eyal N
Int J Infect Dis; 2021 Apr; 105():307-311. PubMed ID: 33592338
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question.
Marjot T; Webb GJ; Barritt AS; Ginès P; Lohse AW; Moon AM; Pose E; Trivedi P; Barnes E
Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):156-158. PubMed ID: 33444545
[No Abstract] [Full Text] [Related]
8. FDA authorizes first single-shot COVID-19 vaccine.
Mullard A
Nat Rev Drug Discov; 2021 Apr; 20(4):251. PubMed ID: 33707753
[No Abstract] [Full Text] [Related]
9. 2020 in 20/20 hindsight.
Chernoff J
Mol Biol Cell; 2021 May; 32(10):1007-1008. PubMed ID: 33914594
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 vaccination programme: a central role for primary care.
Harnden A; Lim WS; Earnshaw A
Br J Gen Pract; 2021; 71(703):52-53. PubMed ID: 33495206
[No Abstract] [Full Text] [Related]
11. Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines.
Steel R; Buchak L; Eyal N
J Med Ethics; 2020 Dec; 46(12):808-812. PubMed ID: 32661074
[TBL] [Abstract][Full Text] [Related]
12. New Vaccine-Manufacturing Methods Are Moving Away From the Egg.
Mertz L
IEEE Pulse; 2021; 12(1):7-11. PubMed ID: 33630735
[TBL] [Abstract][Full Text] [Related]
13. Emerging COVID-19 vaccines: A rheumatology perspective.
Byravan S; Fardanesh A; Tahir H; Moorthy A
Int J Rheum Dis; 2021 Feb; 24(2):144-146. PubMed ID: 33523564
[No Abstract] [Full Text] [Related]
14. COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer.
Chen Y; Cheng L; Lian R; Song Z; Tian J
Biosci Trends; 2021 May; 15(2):64-73. PubMed ID: 33746182
[TBL] [Abstract][Full Text] [Related]
15. Covid-19 vaccines and new mutant strains impacting the pandemic.
Matta S; Rajpal S; Chopra KK; Arora VK
Indian J Tuberc; 2021 Apr; 68(2):171-173. PubMed ID: 33845947
[No Abstract] [Full Text] [Related]
16. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
17. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
Rid A; Lipsitch M; Miller FG
JAMA; 2021 Jan; 325(3):219-220. PubMed ID: 33315080
[No Abstract] [Full Text] [Related]
18. COVID-19 may become nanomedicine's finest hour yet.
Friedrichs S; Bowman DM
Nat Nanotechnol; 2021 Apr; 16(4):362-364. PubMed ID: 33854220
[No Abstract] [Full Text] [Related]
19. Protective Effect of COVID-19 Vaccine Among Health Care Workers During the Second Wave of the Pandemic in India.
Victor PJ; Mathews KP; Paul H; Mammen JJ; Murugesan M
Mayo Clin Proc; 2021 Sep; 96(9):2493-2494. PubMed ID: 34366135
[No Abstract] [Full Text] [Related]
20. External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European population.
Terzikhan N; Hofman A; Goudsmit J; Ikram MA
Eur J Epidemiol; 2021 Mar; 36(3):319-324. PubMed ID: 33634346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]